← Back to Clinical Trials
Recruiting NCT07889583

NCT07889583 Acromial Morphology: Reliability of CT-based Assessment and Relationship With Age in a Series of 420 Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07889583
Status Recruiting
Phase —
Sponsor University Hospital, Strasbourg, France
Condition Shoulder Impingement Syndrome
Study Type OBSERVATIONAL
Enrollment 420 participants
Start Date 2026-01-22
Primary Completion 2026-11-22

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 98 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 420 participants in total. It began in 2026-01-22 with a primary completion date of 2026-11-22.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates the reliability of CT-based assessment of acromial morphology and its relationship with age, in order to improve understanding of shoulder pathologies such as subacromial impingement and rotator cuff tears.

Eligibility Criteria

Inclusion Criteria: * Subjects aged 20 to 89 years * Shoulder CT or arthro-CT performed at Strasbourg University Hospitals * Examination performed between 02/01/2009 and 11/12/2023 * Independent indication for imaging * No documented opposition to reuse of medical data for research Exclusion Criteria: * Imaging not performed * Poor image quality * Inability to perform 3D reconstruction * Duplicate examination within the same age group * History of acromial fracture * Previous surgery interfering with acromial analysis (arthroplasty, acromioplasty, osteosynthesis, arthrodesis) * Shoulder pathology interfering with acromial analysis (severe acromioclavicular arthropathy, humeral head osteonecrosis, glenohumeral dysplasia)

Contact & Investigator

Central Contact

Philippe CLAVERT, MD, PhD

✉ philippe.clavert@chru-strasbourg.fr

📞 33 3 88 11 67 68

Frequently Asked Questions

Who can join the NCT07889583 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 98 Years, studying Shoulder Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07889583 currently recruiting?

Yes, NCT07889583 is actively recruiting participants. Contact the research team at philippe.clavert@chru-strasbourg.fr for enrollment information.

Where is the NCT07889583 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07889583 clinical trial?

NCT07889583 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 420 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology